David R. Repaske

2.0k total citations
37 papers, 1.4k citations indexed

About

David R. Repaske is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Social Psychology. According to data from OpenAlex, David R. Repaske has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Social Psychology. Recurrent topics in David R. Repaske's work include Neuroendocrine regulation and behavior (10 papers), Diabetes Management and Research (7 papers) and Phosphodiesterase function and regulation (6 papers). David R. Repaske is often cited by papers focused on Neuroendocrine regulation and behavior (10 papers), Diabetes Management and Research (7 papers) and Phosphodiesterase function and regulation (6 papers). David R. Repaske collaborates with scholars based in United States, Canada and Lebanon. David R. Repaske's co-authors include Julius Adler, Marco Conti, Korey K. Hood, Johannes V. Swinnen, Dennis Drotar, D L Garbers, Lori M. Laffel, Michael F. Goy, Charles V. Vorhees and Tracy M. Reed and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Endocrine Reviews.

In The Last Decade

David R. Repaske

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Repaske United States 20 847 288 247 226 201 37 1.4k
Sabatino Ventura Australia 24 486 0.6× 297 1.0× 96 0.4× 109 0.5× 173 0.9× 78 1.5k
Shoji Harada Japan 29 950 1.1× 214 0.7× 264 1.1× 77 0.3× 68 0.3× 81 2.3k
Haim Rosen Israel 25 910 1.1× 188 0.7× 141 0.6× 40 0.2× 174 0.9× 49 1.9k
Allan M. Judd United States 29 954 1.1× 790 2.7× 254 1.0× 87 0.4× 88 0.4× 97 2.5k
Francisco J. López United States 28 618 0.7× 468 1.6× 400 1.6× 102 0.5× 139 0.7× 72 2.4k
Marc B. Cox United States 27 1.8k 2.1× 435 1.5× 248 1.0× 57 0.3× 185 0.9× 50 2.8k
S. Batra Sweden 23 451 0.5× 175 0.6× 237 1.0× 40 0.2× 101 0.5× 79 1.5k
Hanns-Christian Tillmann Switzerland 12 492 0.6× 491 1.7× 482 2.0× 57 0.3× 348 1.7× 37 1.8k
Anna Benrick Sweden 26 453 0.5× 344 1.2× 264 1.1× 92 0.4× 50 0.2× 57 2.2k
D.J.A. Eckland United Kingdom 18 435 0.5× 642 2.2× 120 0.5× 51 0.2× 66 0.3× 37 1.5k

Countries citing papers authored by David R. Repaske

Since Specialization
Citations

This map shows the geographic impact of David R. Repaske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Repaske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Repaske more than expected).

Fields of papers citing papers by David R. Repaske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Repaske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Repaske. The network helps show where David R. Repaske may publish in the future.

Co-authorship network of co-authors of David R. Repaske

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Repaske. A scholar is included among the top collaborators of David R. Repaske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Repaske. David R. Repaske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guertin, Kristin A., David R. Repaske, Eli S. Williams, et al.. (2024). Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project. Genome Medicine. 16(1). 31–31. 8 indexed citations
2.
Önengüt-Gümüşcü, Suna, et al.. (2023). Precision Medicine in Type 1 Diabetes. Journal of the Indian Institute of Science. 103(1). 335–351. 8 indexed citations
3.
Quigley, Charmian A., Anthony J. Zagar, David M. Brown, et al.. (2013). United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. International Journal of Pediatric Endocrinology. 2013(1). 6–6. 18 indexed citations
4.
Chima, Ranjit S., Pamela J. Schoettker, Kartik Varadarajan, et al.. (2012). Reduction in Hypoglycemic Events in Critically Ill Patients on Continuous Insulin Following Implementation of a Treatment Guideline. Quality Management in Health Care. 21(1). 20–28. 3 indexed citations
5.
Ingerski, Lisa M., Lori M. Laffel, Dennis Drotar, David R. Repaske, & Korey K. Hood. (2010). Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes. Pediatric Diabetes. 11(8). 563–571. 50 indexed citations
6.
Cortina, Sandra, David R. Repaske, & Korey K. Hood. (2009). Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes. Pediatric Diabetes. 11(5). 337–344. 28 indexed citations
7.
Repaske, David R. & Stuart Handwerger. (2008). Making the transition from pediatric to adult endocrinology services. Nature Clinical Practice Endocrinology & Metabolism. 4(9). 492–493. 1 indexed citations
8.
Siuciak, Judith A., Sheryl A. McCarthy, Douglas S. Chapin, et al.. (2007). Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme. Neuropharmacology. 53(1). 113–124. 48 indexed citations
9.
Staveren, Wilma C.G. van, Harry W.M. Steinbusch, M. Markerink–van Ittersum, et al.. (2003). mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. The Journal of Comparative Neurology. 467(4). 566–580. 128 indexed citations
10.
Santiprabhob, Jeerunda, James E. Browning, & David R. Repaske. (2002). A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Molecular Genetics and Metabolism. 77(1-2). 112–118. 17 indexed citations
11.
King, Jennifer L., et al.. (2001). Antenatal Corticosteroids and Newborn Screening for Congenital Adrenal Hyperplasia. Archives of Pediatrics and Adolescent Medicine. 155(9). 1038–1038. 17 indexed citations
12.
Browning, James E., et al.. (1998). Genomic structure and chromosome location of the murine PDE1B phosphodiesterase gene. Mammalian Genome. 9(7). 571–576. 19 indexed citations
13.
Gagliardi, Priscila, Sergio Bernasconi, & David R. Repaske. (1997). Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23→Val in Neurophysin II1. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3643–3646. 37 indexed citations
14.
Repaske, David R., R. Medlej, M.R.S. Krishnamani, et al.. (1997). Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala−1→Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor1. The Journal of Clinical Endocrinology & Metabolism. 82(1). 51–56. 55 indexed citations
15.
Repaske, David R., et al.. (1996). Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.. The Journal of Clinical Endocrinology & Metabolism. 81(6). 2328–2334. 16 indexed citations
16.
Repaske, David R., Jackie D. Corbin, Marco Conti, & Michael F. Goy. (1993). A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience. 56(3). 673–686. 75 indexed citations
17.
Repaske, David R. & John A. Phillips. (1992). Chapter 21 The molecular biology of human hereditary central diabetes insipidus. Progress in brain research. 93. 295–308. 8 indexed citations
18.
Conti, Marco, et al.. (1991). Hormonal Regulation of Cyclic Nucleotide Phosphodiesterases*. Endocrine Reviews. 12(3). 218–234. 126 indexed citations
19.
Repaske, David R., et al.. (1990). Molecular Analysis of Autosomal Dominant Neurohypophyseal Diabetes Insipidus*. The Journal of Clinical Endocrinology & Metabolism. 70(3). 752–757. 32 indexed citations
20.
Butler, Merlin G., et al.. (1987). High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome. Cancer Genetics and Cytogenetics. 24(1). 129–135. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabatino Ventura Breakdown of academic impact, for papers by Shoji Harada Breakdown of academic impact, for papers by Haim Rosen Breakdown of academic impact, for papers by Allan M. Judd Breakdown of academic impact, for papers by Francisco J. López Breakdown of academic impact, for papers by Marc B. Cox Breakdown of academic impact, for papers by S. Batra Breakdown of academic impact, for papers by Hanns-Christian Tillmann Breakdown of academic impact, for papers by Anna Benrick Breakdown of academic impact, for papers by D.J.A. Eckland
Rankless by CCL
2026